News

Filter

Cell Therapeutics appeals FDA decision on pixantrone NDA for non-Hodgkin's lymphoma

06-12-2010

USA-based Cell Therapeutics (Nasdaq and MTA: CTIC) says that it has submitted a formal appeal to the…

Cell TherapeuticsNorth AmericaOncologyPharmaceuticalpixantronePixuvirRegulation

EMEA validates Cell Therapeutics’ expanded pixantrone PIP

17-08-2010

Seattle, USA-based Cell Therapeutics (CTI) says it has received notice that the European Medicines Agency…

Cell TherapeuticsEuropeNorth AmericaOncologyPharmaceuticalpixantronePixuvriRare diseasesRegulation

EU regulator approves Pfizer’s Lipitor for children; Cell Thera files pixantrone pediatric investigation plan with EMEA

06-07-2010

The European Commission has approved a new chewable form of global drugs behemoth Pfizer’s Lipitor…

Cardio-vascularCell TherapeuticsEuropeLipitorOncologyPfizerPharmaceuticalpixantroneRare diseasesRegulationResearch

Italian medicines agency OKs NerPharMa facility to make Cell Therapeutics' pixantrone in EU

16-06-2010

The Italian Medicines Agency (AIFA), the national authority responsible for drug regulation in Italy,…

Cell TherapeuticsOncologyPharmaceuticalpixantronePixuvriRegulation

US FDA calls for more info on Cell Thera’s pixantrone NDA, and firm says it will file for expanded access for NHL patients

09-04-2010

Seattle, USA-based Cell Therapeutics revealed this morning that it had received a Complete Response Letter…

BiotechnologyCell TherapeuticsNorth AmericaOncologyPharmaceuticalpixantronePixuvriRegulation

Back to top